A detailed history of Cresset Asset Management, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Cresset Asset Management, LLC holds 30,612 shares of TEVA stock, worth $524,077. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,612
Previous 27,763 10.26%
Holding current value
$524,077
Previous $451,000 22.17%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.81 - $18.96 $45,042 - $54,017
2,849 Added 10.26%
30,612 $551,000
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $86,955 - $118,389
6,804 Added 32.46%
27,763 $451,000
Q1 2024

May 15, 2024

BUY
$10.67 - $14.43 $31,689 - $42,857
2,970 Added 16.51%
20,959 $295,000
Q4 2023

Feb 14, 2024

SELL
$8.12 - $10.63 $3,377 - $4,422
-416 Reduced 2.26%
17,989 $187,000
Q3 2023

Nov 14, 2023

BUY
$7.48 - $10.7 $47,079 - $67,345
6,294 Added 51.97%
18,405 $187,000
Q2 2023

Aug 14, 2023

BUY
$7.2 - $9.47 $87,199 - $114,691
12,111 New
12,111 $91,000
Q4 2022

Feb 14, 2023

BUY
$7.95 - $9.48 $3,116 - $3,716
392 Added 1.93%
20,691 $188,000
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $480 - $836
70 Added 0.35%
20,299 $164,000
Q2 2022

Aug 15, 2022

SELL
$7.38 - $10.4 $9,623 - $13,561
-1,304 Reduced 6.06%
20,229 $150,000
Q1 2022

May 16, 2022

SELL
$7.33 - $9.39 $23,697 - $30,357
-3,233 Reduced 13.05%
21,533 $202,000
Q4 2021

Feb 10, 2022

BUY
$7.9 - $10.19 $7,568 - $9,762
958 Added 4.02%
24,766 $198,000
Q3 2021

Nov 15, 2021

BUY
$8.38 - $10.18 $13,424 - $16,308
1,602 Added 7.21%
23,808 $232,000
Q2 2021

Aug 10, 2021

SELL
$9.9 - $11.56 $2,554 - $2,982
-258 Reduced 1.15%
22,206 $220,000
Q1 2021

May 12, 2021

BUY
$10.34 - $12.81 $19,129 - $23,698
1,850 Added 8.97%
22,464 $260,000
Q4 2020

Feb 11, 2021

BUY
$8.61 - $11.04 $5,019 - $6,436
583 Added 2.91%
20,614 $199,000
Q2 2020

Aug 04, 2020

BUY
$8.12 - $13.12 $11,765 - $19,010
1,449 Added 7.8%
20,031 $247,000
Q1 2020

May 15, 2020

BUY
$6.69 - $13.45 $1,465 - $2,945
219 Added 1.19%
18,582 $167,000
Q4 2019

Feb 10, 2020

SELL
$6.53 - $10.72 $3,271 - $5,370
-501 Reduced 2.66%
18,363 $180,000
Q3 2019

Nov 13, 2019

BUY
$6.16 - $9.6 $388 - $604
63 Added 0.34%
18,864 $130,000
Q2 2019

Aug 12, 2019

SELL
$8.12 - $15.72 $4,254 - $8,237
-524 Reduced 2.71%
18,801 $174,000
Q1 2019

May 15, 2019

BUY
$15.58 - $20.01 $293,106 - $376,448
18,813 Added 3674.41%
19,325 $303,000
Q4 2018

May 21, 2019

BUY
$14.59 - $23.84 $7,470 - $12,206
512 New
512 $8,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.